NorthWest Biotherapeutics Inc (NWBO)

[abeta]

Matjaz30 December 2015 at 08:34

Please see the answer regarding costs from Ms. Carol Powers (I guess she is reponsible for public/patient relations) at NWBio:

DCVax-L is a labor intensive, custom-made vaccine based on the patient’s unique biomarkers, using the patient’s own dendritic cells. The vaccine is made in a "batch" manufacturing process, meaning the entire course of vaccine doses is manufactured at one time. In addition, DCVax-L must pass strict quality control standards before it can be released. The charges are as follows:


Total cost €53,000 (Euros) for the Tumor Lysate, DCVax Production and first 3 injections
• Deposit of €19,000 (Euros) due at time of Tumor Lysate production
• Balance of €34,000 (Euros) due at time of Leukapheresis processing

· Subsequent injections (injection 4 and following) cost €17,000 (Euros) each, due at the time of injection
• Leukapheresis costs range from $3,500 to $5,000 depending on the apheresis center and if a central line is required

· Initial consultation fee with UK physician £275 - £500 (British Pounds Sterling) * fees vary with the physician

• Shipping fees for tumor tissue, lysate, and DCVax-L are variable based on location but can be in the range of $1,200 to $1,800 or more

· VAT tax 20% - €10,600 (Euros) paid when the first three doses of vaccine are shipped

· Subsequent doses cost €17,000 (Euros) each and the VAT tax is 20% - €3,400 (Euros) paid prior to administration of the vaccine

• Physician’s charge for administering each dose of DCVax-L in the UK £1,125 - £1,500 * (British Pounds Sterling) * fees vary with the physician

insert-text-here